About Dr. Ramaswamy Valliappan
I am a board licensed physician seasoned as Pharmaceutical Physician (in Global Drug Development and Pharmacovigilance / Drug Safety) with nearly over 22 plus years of experience as a Co-Principal Investigator and in Site Management, Clinical Development & Pharmacovigilance arena across various transnational ITES, CROs and Pharmaceuticals to name a few like Accenture, Quintiles (IQVIA), Novartis Pharmaceuticals, Strides Arcolab, Stelis Biopharma, Bioclinica (Qinecsa), and more.
I sit at the intersection of clinical medicine, advanced data science, and global regulatory strategy. With over 22 years in the pharmaceutical industry, beginning with direct patient care in multinational clinical trials, my mission is to ensure the world's most innovative medicines are also the world's safest. My expertise lies in building and leading predictive pharmacovigilance programs for the next generation of treatments: new chemical entities, novel biologics, advanced vaccines, and revolutionary cell&gene- and radioligand therapies. I have a deep understanding of the entire drug lifecycle, from early development to post-market surveillance, and hold critical experience supporting Chief Safety Officers and with EU Qualified Person for Pharmacovigilance (EU QPPV), navigating the highest levels of safety governance.
I am passionate about harnessing the power of AI and automation to not only improve efficiency but to uncover a safety insights that were previously impossible to find. Ultimately, I build and mentor world-class teams dedicated to protecting patients and securing the success of groundbreaking therapies. My mission is to improve global patient safety through medically sound, technologically advanced pharmacovigilance solutions.
In 2024, I earned the “Generative AI Mastermind” certification under the guidance of leading AI educators, further empowering me to architect and implement AI-driven strategies across global drug safety and clinical development.
My Journey of Resilience
In 2021, I experienced a stroke causing right hemiparesis and slurred speech. After dedicated rehabilitation, I’ve almost recovered with my motor fumctions, performing my activities of daily living seamlessly & independently; and continuing professional contributions. My story is one of strength and commitment — to science, safety, and service.
Watch the Transition
With the support of a global network of peers, I founded **M/s. PHOENIX NEUMED (a RR Group)**, a non-profit initiative dedicated to providing free, expert-level consulting and training.
Our mission is to equip aspiring healthcare professionals and emerging pharma/CRO organizations with the strategic tools to succeed. We offer pro bono guidance across **the full spectrum of Pharmacovigilance—from xEVMPD setup to PSMF authoring and end-to-end process mastery as well as specialized support in clinical development, data management, and regulatory affairs.**
This work is a way of giving back to the industry I am passionate about. In accordance with professional ethics, my continuation of these services is subject to review based on future employment in pharmacovigilace or patient safety in pharmaceuticals or with health regulators to avoid any conflict of interest.